Special offer. See more information about Outbyte and uninstall instructions. Please review EULA and Privacy policy.

AI-MARRVEL helped researchers prioritize a rare BRSK1 variant as a candidate explanation for an unresolved case. Follow-up work linked variants in the gene to a neurodevelopmental disorder, but the AI tool did not diagnose patients on its own: family matching and laboratory experiments supplied additional evidence.

What did AI-MARRVEL contribute?

In an unresolved case from the Texome Project, standard genetic analyses of a parent and child had not identified an explanation. AI-MARRVEL analyzed genomic data and highlighted a rare change in BRSK1 as a promising candidate. The tool’s role was to help prioritize a possible lead, not to establish a diagnosis by itself.

Researchers then used GeneMatcher to find other families with rare variants in the same gene and investigated the variants in fruit flies. The combination of a candidate from genomic analysis, matching cases, and experimental findings supported the link between BRSK1 and the disorder. The available report does not provide an accuracy rate, sensitivity estimate, benchmark, or evidence that AI-MARRVEL will generalize to other patients or genes. MARRVEL’s website describes the genomic resource; it is not evidence of clinical diagnostic performance.

What did the BRSK1 study find?

The study, “Monoallelic variants in BRSK1 are associated with a neurodevelopmental disorder with or without epilepsy,” reports 10 affected individuals from seven unrelated families. Nine individuals were identified through GeneMatcher after the initial Texome Project case.

Special offer. See more information about Outbyte and uninstall instructions. Please review EULA and Privacy policy.

All 10 had some degree of developmental delay. Reported features included:

  • Delayed speech and language
  • Intellectual disability
  • Autism spectrum disorder and ADHD
  • Anxiety
  • Low muscle tone and microcephaly

Two of the 10 individuals had seizures, so epilepsy was not present in everyone in this small series. Symptoms and severity varied, including among relatives carrying the same variant. These observations describe the people reported in the study; they do not establish how often each feature occurs across all people with BRSK1 variants.

What do the fruit-fly experiments show?

The researchers studied sff, the fruit-fly ortholog of human BRSK1. Disabling sff caused movement problems, stress sensitivity, paralysis after heat exposure, and shorter lifespan. Normal human BRSK1 largely corrected movement and neurological problems in the flies, while patient-derived variants restored function only partially.

Three tested alleles—BRSK1 p.Ile202Val, p.Arg237Cys, and p.Thr406Ile—provided partial rescue in the fly experiments but did not normalize neuromuscular-junction morphology or Futsch levels. The authors interpret these results as supporting partial loss of function. They are findings in an animal model, not direct measures of symptoms or severity in human carriers.

Special offer. See more information about Outbyte and uninstall instructions. Please review EULA and Privacy policy.

The institutional account also describes overgrowth of connections between neurons and muscles and increased levels of a protein involved in organizing microtubules when BRSK1 activity was lost. The experiments suggest a possible biological connection, but do not prove that this mechanism explains every clinical feature.

How should a BRSK1 variant be interpreted?

A rare variant is a clue, not automatically a cause of disease. In this report, the case for a link came from several kinds of evidence: clinical findings in affected people, rare variants shared across unrelated families, and functional experiments on selected variants. A person’s variant and symptoms need interpretation in clinical context; the fly results cannot predict an individual’s course.

The Texome Project is described by Texas Children’s Hospital as providing free genetic testing to medically underserved individuals with rare, undiagnosed conditions. That is a specific program for eligible individuals, not a general offer of free testing or a consumer AI diagnosis service.

Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.Support on Ko-Fi

How is this different from another BRSK1 epilepsy study?

A separate 2025 Epilepsia paper studied BRSK1 in an epilepsy-focused cohort. It is related evidence about the gene, but it is not the AI-MARRVEL case or the study of 10 affected individuals.

Special offer. See more information about Outbyte and uninstall instructions. Please review EULA and Privacy policy.
Study Human cohort AI role Experimental model
“Monoallelic variants in BRSK1 are associated with a neurodevelopmental disorder with or without epilepsy” (2026) 10 affected individuals from seven unrelated families AI-MARRVEL prioritized a candidate variant in the initial unresolved case Fruit flies (Drosophila)
“Haploinsufficiency of brain-specific kinase BRSK1 causes epilepsy and neurodevelopmental disorders” (2025) Trio exome sequencing in 394 epilepsy probands; six novel variants in seven probands Not reported as the AI-MARRVEL discovery Mouse knockout and other functional work

The 2025 study broadens the separate epilepsy-focused research on BRSK1, but its participants and experiments must not be added to the 2026 study’s totals.

Sources

Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.